newsfilter
← Latest News
GlobeNewswire·

Galecto Set to Join Russell Microcap® Index

BOSTON, June 20, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company and world leader in galectin biology focused on the development of novel treatments for fibrosis and cancer,